SHP2-IN-9
SHP2-IN-9 is a specific SHP2 inhibitor (IC50 =1.174 μM) with enhanced blood–brain barrier penetration. SHP2-IN-9 shows 85-fold more selective for SHP2 than SHP1. SHP2-IN-9 inhibits SHP2-mediated cell signal transduction and cancer cell proliferation, and inhibits the growth of cervix cancer tumors and glioblastoma growth in vivo[1].
Product Specifications
CAS Number
[2987135-92-0]
Product Name Alternative
NVS-MELK8a (hydrochloride)
UNSPSC
12352005
Target
Phosphatase; SHP2
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/shp2-in-9.html
Purity
98.80
Solubility
DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NCC1=CC=C(C=C1)F)CN2C=NC3=C(C4=C(S3)CCCCC4)C2=O
Molecular Formula
C20H20FN3O2S
Molecular Weight
385.46
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
EIF2B2 (Translation Initiation Factor eIF-2B Subunit beta, S20I15, S20III15, eIF-2B GDP-GTP Exchange Factor Subunit beta, EIF2BB) (FITC)
EIF2B2 (Translation Initiation Factor eIF-2B Subunit beta, S20I15, S20III15, eIF-2B GDP-GTP Exchange Factor Subunit beta, EIF2BB) (FITC)